Norah M. van Mello, M. D. , Femke Mol, M. D. , Willem M. Ankum, M. D

Slides:



Advertisements
Similar presentations
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
Advertisements

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Time to pregnancy after a previous miscarriage in subfertile couples
Volume 383, Issue 9927, Pages (April 2014)
Pregnancy outcome after preimplantation genetic screening or natural conception in couples with unexplained recurrent miscarriage: a systematic review.
Integration of immunodeficiency virus in oocytes via intracytoplasmic injection: possible but extremely unlikely  Marjan M.C. Steenvoorden, Ph.D., Marion.
Severe maternal morbidity in ectopic pregnancy is not associated with maternal factors but may be associated with quality of care  Norah M. van Mello,
Couples dropping out of a reimbursed intrauterine insemination program: what is their prognostic profile and why do they drop out?  Inge M. Custers, M.D.,
Effectiveness of intrauterine insemination in subfertile couples with an isolated cervical factor: a randomized clinical trial  Pieternel Steures, M.D.,
Inge M. Custers, M. D. , Pieternel Steures, M. D
Esther Leushuis, M. D. , Jan Willem van der Steeg, Ph. D. , M. D
Role of semen analysis in subfertile couples
Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage 
Soyoung Bae, M.D., Joseph Karnitis, M.D.  Fertility and Sterility 
Can noninvasive diagnostic tools predict tubal rupture or active bleeding in patients with tubal pregnancy?  Ben W.J Mol, M.D., Petra J Hajenius, M.D.,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Pregnancies of unknown location after in vitro fertilization: minimally invasive management with Karman cannula aspiration  Paula Brady, M.D., Anthony.
Performance of human chorionic gonadotropin curves in women at risk for ectopic pregnancy: exceptions to the rules  Christopher B. Morse, B.A., Mary D.
Esther Leushuis, M. D. , Jan Willem van der Steeg, M. D
N. M. van Mello, F. Mol, B. C. Opmeer, E. W. de Bekker-Grob, M. L
Pregnancy outcome after preimplantation genetic screening or natural conception in couples with unexplained recurrent miscarriage: a systematic review.
"Patient-centered fertility treatment": what is required?
Early loss rates of entire pregnancies after assisted reproduction are lower in twin than in singleton pregnancies  Alexandra Matias, M.D., Giovanni B.
Isabel Cerveira, M. D. , Cristina Costa, M. D. , Fernando Santos, M. D
Johannes W. Trum, M. D. , Ben W. J. Mol, M. D. , Yvonne Pannekoek, Ph
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,
Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective.
Medical treatment of ectopic pregnancy: a committee opinion
Live birth of twins derived from zona-free oocytes
Modified natural cycle in in vitro fertilization
Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy  Beata E. Seeber, M.D., Mary D.
How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity  Katherine.
Alka Prakash, M. D. , Susan Laird, Ph. D. , Elizabeth Tuckerman, M. Sc
Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review  Seema Menon, M.D., John.
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
Are serum human chorionic gonadotropin clearance curves of use in monitoring methotrexate treatment in cervical pregnancy?  Petra J. Hajenius, M.D., Daphne.
Impact of assisted reproductive technology on the incidence of multiple-gestation infants: a population perspective  Irma Scholten, M.D., Georgina M.
Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study  Li Wei, Ph.D., Thomas MacDonald, M.D.,
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Inge M. Custers, M. D. , Pieternel Steures, M. D
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
From partner's desk to iPad
Mark A. Zakaria, M. D. , Mazen E. Abdallah, M. D. , Valerie I
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision- analytic model  Lobke M. Moolenaar, M.D., Frank J.M. Broekmans,
Time to pregnancy after a previous miscarriage in subfertile couples
Pete N. Lohstroh, B. S. , James W. Overstreet, M. D. , Ph. D
Eva Balkenende, Taghride Dahhan, M. D. , Fulco van der Veen, M. D, Ph
The additional value of ovarian hyperstimulation in intrauterine insemination for couples with an abnormal postcoital test and a poor prognosis: a randomized.
Aviad Cohen, M. D. , Guy Bibi, M. D. , Benny Almog, M. D
Are gestational age and endometrial thickness alternatives for serum human chorionic gonadotropin as criteria for the diagnosis of ectopic pregnancy? 
Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience  Tracy N. Hadnott, B.A., Harley.
HIV couples' anxiety and risk taking during ART
Cost-effectiveness of hysterosalpingography, laparoscopy, and Chlamydia antibody testing in subfertile couples  Ben W.J Mol, M.D., Ph.D., John A Collins,
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D. 
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
L. M. Cookingham, E. H. Duran, R. P. Goossen, D. K. Shah, A. Sparks, B
Rachana V. Garde, M. D. , Vuk P. Jovanovic, M. D. , Grace M
Kurt T Barnhart, M. D. , M. S. C. E. , Paolo Rinaudo, M. D. , Ph. D
Saad Elzanaty, M.D., Ph.D., Johan Malm, M.D., Ph.D. 
Integration of immunodeficiency virus in oocytes via intracytoplasmic injection: possible but extremely unlikely  Marjan M.C. Steenvoorden, Ph.D., Marion.
Early pregnancy loss in in vitro fertilization (IVF) is a positive predictor of subsequent IVF success  G.Wright Bates, M.D., Elizabeth S Ginsburg, M.D. 
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients’ health-related quality of.
Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate  Pythia T Nieuwkerk,
Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:
Is chromosome testing of the second miscarriage cost saving
Cost-effectiveness of treatment strategies in women with PCOS who do not conceive after six cycles of clomiphene citrate  Lobke M. Moolenaar, Marleen.
Presentation transcript:

Ectopic pregnancy: how the diagnostic and therapeutic management has changed  Norah M. van Mello, M.D., Femke Mol, M.D., Willem M. Ankum, M.D., Ph.D., Ben Willem Mol, M.D., Ph.D., Fulco van der Veen, M.D., Ph.D., Petra J. Hajenius, M.D., Ph.D.  Fertility and Sterility  Volume 98, Issue 5, Pages 1066-1073 (November 2012) DOI: 10.1016/j.fertnstert.2012.09.040 Copyright © 2012 Terms and Conditions

Figure 1 (A) Diagnostic algorithm for ectopic pregnancy derived from ACOG Clinical Management Guideline, No. 94, June 2008 (27). (B) Diagnostic algorithm for early pregnancy loss derived from RCOG Green Top Guideline, No. 25, October 2006 (28). D&C = dilation and curettage. *Discriminatory Zone cutoff of 1,500–2,500 IU/L should be set by each institution based on that hospital’s success in correctly identifying ectopic pregnancies, based mostly on equipment used and expertise of the sonographers. **Abnormal rise or fall if the hCG does not fall 21%–35% in 2 days (depending on the initial value). ***Normal fall is a rapid decline in hCG value, consistent with a miscarriage that may resolve spontaneously. Fertility and Sterility 2012 98, 1066-1073DOI: (10.1016/j.fertnstert.2012.09.040) Copyright © 2012 Terms and Conditions